Drug Shortage Report for TEVA-LANSOPRAZOLE
Report ID | 145783 |
Drug Identification Number | 02280515 |
Brand name | TEVA-LANSOPRAZOLE |
Common or Proper name | LANSOPRAZOLE 15MG DR CAPS |
Company Name | TEVA CANADA LIMITED |
Market Status | MARKETED |
Active Ingredient(s) | LANSOPRAZOLE |
Strength(s) | 15MG |
Dosage form(s) | CAPSULE (DELAYED RELEASE) |
Route of administration | ORAL ORAL |
Packaging size | 100 |
ATC code | A02BC |
ATC description | DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD) |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2021-09-15 |
Estimated end date | Unknown |
Actual end date | |
Shortage status | Actual shortage |
Updated date | 2024-03-18 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 30 NOVOPHARM COURT TORONTO, ONTARIO CANADA M1B 2K9 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v53 | 2024-03-18 | French | Compare |
v52 | 2024-03-18 | English | Compare |
v51 | 2024-02-01 | French | Compare |
v50 | 2024-02-01 | English | Compare |
v49 | 2024-01-25 | French | Compare |
v48 | 2024-01-25 | English | Compare |
v47 | 2024-01-18 | French | Compare |
v46 | 2024-01-18 | English | Compare |
v45 | 2023-11-03 | French | Compare |
v44 | 2023-11-03 | English | Compare |
v43 | 2023-10-12 | French | Compare |
v42 | 2023-10-12 | English | Compare |
v41 | 2023-10-03 | French | Compare |
v40 | 2023-10-03 | English | Compare |
v39 | 2023-08-04 | French | Compare |
v38 | 2023-08-04 | English | Compare |
v37 | 2023-07-27 | French | Compare |
v36 | 2023-07-27 | English | Compare |
v35 | 2023-07-20 | French | Compare |
v34 | 2023-07-20 | English | Compare |